LOW RISKCONDITIONAL

Chance an Overdose Death Involved Bromazolam (2023)

1.6% of overdose deaths (1,734 deaths)

Conditional probability in US

In 2023, Bromazolam was involved in 1.6% of overdose deaths (1,734 deaths), according to NCHS literal-text overdose mortality analysis.

NCHS reported 1,734 drug overdose deaths involving Bromazolam in 2023, ranking it number 15 among the drugs most frequently mentioned in overdose death records. That equals 1.6% of the 106,352 U.S. drug overdose deaths in the report's 2023 table.

This is a conditional probability, not the probability that a random person dies from Bromazolam. The denominator is drug overdose deaths, and the numerator is overdose deaths in which Bromazolam was identified from death-certificate literal text. NCHS emphasizes that overdose deaths may involve multiple drugs, so these drug-specific percentages are not mutually exclusive and should not be added together.

The decision value is practical risk interpretation. Drug-specific overdose data helps separate the overall overdose crisis into substances and combinations that call for different responses: naloxone access, fentanyl test strips where legal and appropriate, medication-assisted treatment, careful prescribing, avoiding solitary use, safer storage, and faster emergency response. For Bromazolam, the report notes: Bromazolam entered the top 15 in 2023 after emerging in recent death-certificate data, with rates increasing from 2021 to 2023.

There are important limitations. The method relies on what medical certifiers wrote on death certificates, and NCHS says the reported numbers should be considered minimum counts because additional deaths may have involved the drug without it being captured in the literal text. Reporting improved over time, so trend comparisons require caution.

CDCNCHSdrug overdose2023 overdose deathsconditional probabilityBromazolam

Use This in a Decision

Plug this probability into our expected value calculator to make a data-driven decision.

Start a Decision